The ‘Vaccine Court’ Is Hazardous To Your Health

The National Childhood Vaccine Injury Compensation Act was passed in 1986, under the shadow of multi-million dollar jury verdicts against the makers of the Diphtheria Pertussis and Tetanus (DPT) vaccine. Congress announced that vaccine injuries and deaths are real and provided that vaccine-injured children and their families would be financially compensated. Part of the larger Vaccine Act, the Vaccine Injury Compensation Program (VICP) was modeled after workers’ compensation programs. It was to be a “no-fault” program.

Very well. As one of the earliest “vaccine attorneys”—a very limited practice niche—I know first-hand it didn’t work that way. I practiced in the National Childhood Vaccine Injury Compensation Program for more than 25 years after its inception in 1988, and have been personally involved in over 100 vaccine-injury cases. I represented an entire fragile population in omnibus proceedings. I was able to obtain reversal in the Federal Circuit Court of Appeals of the denial of compensation to a vaccine-injured child in a case that the government appealed to the United States Supreme Court as Shalala v. Whitecotton. It was the only Vaccine Act case to be argued before the United States Supreme Court until Sebelius v. Cloer in 2013, where I was co-counsel for the vaccine-injured petitioner, and guided the attorneys-fees litigation that the Supreme Court upheld on review against the government’s objection. I have seen the injured and their families cruelly oppressed.

From the passing of the legislation in 1986, the process has been rigged, one major step at a time, in favor of the vaccine-industrial complex. Policy makers nationwide are yearning, with financial support and lobbying from the pharmaceutical industry, for mandatory vaccination. Before further compulsory vaccinationlegislation passes—on a state or federal level—the failure of the VICP must be acknowledged and properly addressed. The VICP creates a classic moral hazard, granting immunity from suit to the vaccine industry while providing insurance against any loss. The vaccine-industrial complex has become a thriving giant; according to a 2013 report presented by the Pharmaceutical Research and Manufacturers of America, nearly300 vaccines were reported to be in development. Its lobbying money drives agency denial of the reality of vaccine injury, which in turn permeates policy decisions in a sinister fashion.

Keep reading

South Korea sticks to flu vaccine plan despite safety fears after 25 die

South Korean officials refused on Thursday to suspend a seasonal influenza inoculation effort, despite growing calls for a halt, including an appeal from a key group of doctors, after the deaths of at least 25 of those vaccinated.

Health authorities said they found no direct links between the deaths and the vaccines.

At least 22 of the dead, including a 17-year-old boy, were part of a campaign to inoculate 19 million teenagers and senior citizens for free, the Korea Disease Control and Prevention Agency (KDCA) said.

“The number of deaths has increased, but our team sees low possibility that the deaths resulted from the shots,” the agency’s director, Jeong Eun-kyeong, told parliament.

Keep reading

AstraZeneca COVID-19 vaccine trial Brazil volunteer dies, trial to continue

Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca AZN.L and Oxford University had died but added that the trial would continue.

Oxford confirmed the plan to keep testing, saying in a statement that after careful assessment “there have been no concerns about safety of the clinical trial.” Brazilian newspaper O Globo reported that the volunteer had been given a placebo and not the trial vaccine, citing unnamed sources.

Anvisa provided no further details, citing medical confidentiality of those involved in trials.

Keep reading

Vaccine suppliers given indemnity for ‘inevitable’ side effects

The Morrison government has given the suppliers of two COVID-19 vaccines indemnity against liability for rare side effects that experts say are “inevitable” when a vaccine is rolled out.

But the government will not set up a statutory compensation scheme, which the president of the Australian Medical Association, Omar Khorshid, said meant Australians who suffered “extremely rare” side effects from the vaccines would face a tough battle to seek compensation.

Keep reading